After more than three decades of discussion within the medical community, an international panel of experts has decided to rename Polycystic Ovary Syndrome (PCOS), one of the most common hormonal disorders affecting women of reproductive age. The new name is intended to better reflect the true nature of the condition and eliminate the misunderstandings associated with the original term.
Why the Original Name Was Considered Inadequate
Polycystic Ovary Syndrome affects approximately 8–13% of women of reproductive age. Although PCOS is commonly associated only with the ovaries, experts have long argued that the name is misleading. Many patients diagnosed with PCOS do not actually have polycystic ovaries, while some women with polycystic ovarian morphology do not meet other diagnostic criteria for the syndrome.
As a result, the name emphasized only one possible manifestation of the condition while overlooking its broader hormonal and metabolic components. This often contributed to confusion among patients and, in some cases, delayed proper diagnosis and treatment.
A New Name Focused on Hormonal and Metabolic Health
After extensive discussion, experts have recommended adopting the term:
**Metabolic Reproductive Syndrome (MRS)**
This name more accurately reflects the two major systems affected by the condition: reproductive health and metabolic function. Women with the syndrome may experience irregular ovulation, menstrual disturbances, elevated androgen levels, fertility challenges, insulin resistance, and increased risk of type 2 diabetes, cardiovascular disease, and obesity.
Helping Patients Better Understand Their Diagnosis
According to specialists, the goal is not merely to introduce a new medical term. The change is intended to improve understanding of the condition among patients, healthcare professionals, and the general public.
For many women, a diagnosis of “polycystic ovary syndrome” created the impression that the disorder was primarily an ovarian problem. In reality, it is a complex systemic condition that affects hormonal regulation, metabolism, and long-term health.
Physicians also emphasize that early diagnosis and appropriate treatment can significantly reduce the risk of future complications. Alongside medical therapy, lifestyle measures such as regular physical activity, a balanced diet, and weight management play an important role in treatment.
What the Change Means for Patients
For women who have already been diagnosed with PCOS, the condition itself and the recommended treatment approaches remain unchanged. The new terminology primarily reflects an effort to describe the disorder for patients and physicians more accurately based on current scientific understanding.
The transition to the new name is expected to occur gradually, and both terms will likely be used in parallel for some time. However, experts believe that the updated terminology will improve communication, facilitate earlier diagnosis, and support more effective patient care.
Ultimately, the name change represents more than a linguistic adjustment. It reflects advances in medical knowledge and a shift from viewing the condition as an isolated ovarian disorder to recognizing it as a complex syndrome affecting multiple important aspects of women’s health.